Andre Xiao

Andre Xiao

Senior Analyst, Public Equity

Andre joined Sofinnova BioEquities as a Senior Analyst in 2023. He focuses on public investments primarily in Medtech and Life Sciences.

Prior to Sofinnova, Andre was an Analyst at Perceptive, where he was focused on the same verticals. Before Perceptive, Andre was at Citadel, where he managed a market neutral Medtech/Life Sciences sleeve under a wider healthcare team.

Andre received his Bachelor’s degree from the Wharton School, where he graduated Summa cum Laude in two years, fastest in school history, with a 4.0 in Finance, top of his class. Additionally he completed two Master’s degrees – simultaneously – at MIT (MBA – Finance), and Harvard (MPH – Infectious Diseases).